- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 90,880 | 05.07.24 16:00:03 | -0,460 | -0,50% | 90,520 | 90,590 | 91,060 | 91,340 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 943,400 | 05.07.24 08:03:14 | -1,400 | -0,15% | 952,400 | 960,600 | 943,400 | 944,800 |
